AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has notified the stock exchanges that its trading window has been closed for designated persons and their immediate relatives under SEBI's Insider Trading Regulations, 2015. This is a standard compliance measure typically undertaken ahead of a board meeting to approve financial results or other material events. The company has not yet specified the reopening date. Trading window closures are routine and signal that a corporate announcement or earnings disclosure may be forthcoming.
No direct impact on shareholders, but the closure usually precedes the announcement of quarterly/annual financial results, so investors can expect a results announcement in the near term.